StonvexLoading…
StonvexStonvexStonvexCore line items from AS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.57B | $5.18B | $4.40B | $3.57B |
Operating Income | $701.80M | $470.80M | $302.50M | $50.60M |
Net Income | $440.40M | $78.40M | $-208.80M | $-252.70M |
EPS (Diluted) | $0.76 | $0.14 | $-0.54 | $-0.66 |
Total Assets | $10.06B | $8.40B | $8.37B | $7.90B |
Total Liabilities | $4.24B | $3.39B | $8.53B | $7.97B |
Cash & Equivalents | $652.30M | $345.40M | $483.40M | $402.00M |
Free Cash Flow OCF − CapEx | $513.30M | $195.60M | $75.40M | $-169.40M |
Shares Outstanding | 557.67M | 553.63M | 384.50M | 384.50M |